Trabeculectomy
9
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (9)
Sponge Application of MMC Versus Suntenon Injection in Trabeculectomy
Ab Interno Gelatin Microstent With MMC vs. Trabeculectomy With MMC: 3 Year Retrospective Cohort Analysis
Evaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTA
The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy
Trabeculectomy Versus Canaloplasty
Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
Multidrug Resistance After Trabeculectomy With Mitomycin C